Skip to main content
JAMA Network logoLink to JAMA Network
. 2026 Mar 19:e262697. Online ahead of print. doi: 10.1001/jama.2026.2697

Names Removed and Added to the Byline

PMCID: PMC13003402  PMID: 41854607

The Original Investigation titled “Expectant Management vs Medication for Patent Ductus Arteriosus in Preterm Infants: the PDA Randomized Clinical Trial,” published on February 17, 2026, was corrected to remove and add names to the byline. “Anne Marie Reynolds, MD, MPH” was removed from the byline and “Praveen K. Chandrasekharan, MD, MS” was added where Dr Reynolds’ name had appeared. Dr Reynolds’ information was added to the “Additional Contributions” section. This article was corrected online.

Reference

  • 1.Laughon MM, Thomas SM, Watterberg KL, et al. ; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network . Expectant management vs medication for patent ductus arteriosus in preterm infants: the PDA randomized clinical trial. JAMA. 2026;335(7):588-599. doi: 10.1001/jama.2025.23330 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from JAMA are provided here courtesy of American Medical Association

RESOURCES